Article

Daily OTC Pearl: Doan’s

Author(s):

Saro Arakelians, PharmD

Doan’s magnesium salicylate tetrahydrate formulation treats pain from backaches.

OTC/Lifestyle Pearl of the Day: Doan’s

Indication: Doan’s magnesium salicylate tetrahydrate formulation treats pain from backaches.

Insight:

  • Offers backache relief in caplet form.
  • Contains magnesium salicylate tetrahydrate 580.
  • Take as directed.
  • Keep away from children.

Source: Amazon.com: Doans Extra Strength Pills 24-Count (3-Pack) : Health & Household

Related Videos
Senior Doctor is examining An Asian patient.
Healthcare, pharmacist and woman at counter with medicine or prescription drugs sales at drug store.
Image Credit: © Birdland - stock.adobe.com
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
Pharmacists, Education, Advocacy, Opioid Awareness Month | Image Credit: Jacob Lund - stock.adobe.com
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
Pharmacists working in a pharmacy -- Image credit: Drazen | stock.adobe.com
Related Content
Image credit: Artur | stock.adobe.com
November 14th 2024

Researchers Assess Burden of RSV Hospitalization Prior to Vaccine Introduction

Kennedy Ferruggia, Assistant Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

frontal lobe atrophy on MRI film probably Frontotemporal Dementia - Image credit: Atthapon | stock.adobe.com
November 14th 2024

Study Shows Shingles Infection Could Be Associated With Dementia

Kennedy Ferruggia, Assistant Editor
Public Health Matters podcast logo
August 22nd 2024

Public Health Matters: Healthcare Advocate Summit Emphasizes Advocates Have a Voice in Creating Solutions

Anesthesia, Semaglutide, Delayed Gastric Emptying, FDA | Image Credit: LIGHTFIELD STUDIOS | stock.adobe.com
November 14th 2024

FDA Adds Delayed Gastric Emptying as Adverse Event on Semaglutide Label

Ashley Gallagher, Associate Editor
AHA 2024: GLP-1, SGLT2 Treatments May Lower Risk of Future Heart Attack, Stroke for Stroke Survivors
November 14th 2024

AHA 2024: GLP-1, SGLT2 Treatments May Lower Risk of Future Heart Attack, Stroke for Stroke Survivors

Aislinn Antrim, MA, Assistant Managing Editor